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Abstract
Prevention of bacterial colonization and consequent biofilm formation remains a major challenge 
in implantable medical devices. Implant-associated infections are not only a major cause of 
implant failures but also their conventional treatment with antibiotics brings further complications 
due to the escalation in multidrug resistance to a variety of bacterial species. Owing to their unique 
properties, antimicrobial peptides (AMPs) have gained significant attention as effective agents to 
combat colonization of microorganisms. These peptides have been shown to exhibit a wide 
spectrum of activities with specificity to a target cell while having a low tendency for developing 
bacterial resistance. Engineering biomaterial surfaces that feature AMP properties, therefore, offer 
a promising approach to prevent implant infections. Here, we engineered a chimeric peptide with 
bifunctionality that both forms a robust solid-surface coating while presenting antimicrobial 
property. The individual domains of the chimeric peptides were evaluated for their solid-binding 
kinetics to titanium substrate as well as for their antimicrobial properties in solution. The 
antimicrobial efficacy of the chimeric peptide on the implant material was evaluated in vitro 
against infection by a variety of bacteria, including Streptococcus mutans, Staphylococcus. 
epidermidis, and Escherichia coli, which are commonly found in oral and orthopedic implant 
related surgeries. Our results demonstrate significant improvement in reducing bacterial 
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colonization onto titanium surfaces below the detectable limit. Engineered chimeric peptides with 
freely displayed antimicrobial domains could be a potential solution for developing infection-free 
surfaces by engineering implant interfaces with highly reduced bacterial colonization property.
Keywords
chimeric peptides; antimicrobial peptide (AMP); titanium binding peptides (TiBP); surface 
functionalization; infection; modular peptides; peptide-based implant coatings
1. INTRODUCTION
Local and systemic infections remain a significant problem in the field of medical device 
implantations. Such infections have been proven to be difficult to treat at the implant site 
using systemic antibiotics due to the unique and complex micro-environment within the 
human body.1–3 Resistance of implant infections to systemic antibiotics and the host 
immune response have fueled substantial interest in the research and development of 
biomaterials to prevent bacterial adhesion or completely eliminating infection.4 To achieve 
this, various kinds of coatings have been developed to improve antimicrobial properties of 
biomaterials surfaces specifically for Ti-based implants including antibiotics loading,5 
covalently attaching antimicrobial peptides,6–9 doping of inorganic bactericides,10 polymer-
based surface functionalization,11,12 nonantibiotic organic bactericide-loaded coatings, and 
antifouling coatings.13 While these methods have been shown to reduce bacterial adhesion 
on implant surfaces, existing immobilization strategies often require cumbersome and 
complex procedures. These include the presence of specific, often covalently bound, 
functional groups on the solid surface, extensive optimization of the procedures that often 
have a limited capacity to be used in practice for modification of a wide variety of implant 
materials.14 Additionally, the loading of antibiotics and other antimicrobial agents onto 
biomaterials has raised concern about a possible link to increased bacterial resistance and 
toxicity.15
To combat the issues of antibiotic resistance and toxicity, we offer a novel surface 
functionalization technique utilizing antimicrobial peptides (AMPs). As an evolutionary 
conserved constituent of the innate immune response AMPs are believed to target the 
negatively charged cell membrane of bacteria and possibly the embedded lipids bearing 
phospholipid head-groups, mediating killing by membrane disruption or transmembrane 
pore formation.16,17 They are effective against a broad range of microorganisms and can 
work synergistically with classical antibiotics, possibly facilitating the access of antibiotics 
to the infection site and, thus, providing an avenue for a more aggressive treatment approach 
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against biofilm formation. Although they can be candidates for clinical applications,18,19 the 
major barrier for the use of AMPs as antibiotics or injectable therapeutics is their 
uncontrolled toxicity or ability to lyse eukaryotic cells.20 To circumvent these potential 
harmful effects, the immobilization of AMP on implant surfaces is a practical way to 
effectively use it as a local therapeutic agent.8 Antimicrobial peptides have been proposed to 
covalently attach to the implant materials such as titanium and hydroxyapatite using silane- 
and thiol-based carbodiimide chemistry or by delivering them via polymer based 
resins.11,12,21 Besides not being biofriendly, these approaches are also not adequate to 
control orientation and structural conformation of the AMPs that could directly affect the 
function of surface-immobilized antimicrobial peptides.8,19
Biomolecular linkers that can induce controlled interactions at the bio/material interface 
while having high affinity to the implant material could also be a way to immobilize AMPs 
onto the implant surfaces. During the past decade, the potential utility of the solid binding 
peptides as surface functionalizing agents has increasingly been demonstrated in a wide 
range of applications including tissue engineering and regenerative and restorative 
medicine.22–25 Specifically, there has been a great deal of interest in identifying and 
characterizing peptides26 that bind to various biomaterials and implants, such as Ti, TiO2, 
Au, Pt, SiO2, calcium phosphate minerals, graphite, and structural polymers.22,24,25,27–29 
Using solid binding peptides, desired biomolecules such as AMPs could be immobilized 
onto the surfaces with orientation control which is critical for their biochemical accessibility.
Building upon the solid-binding peptide approach, we engineered bifunctional peptides that 
are composed of both a solid-binding peptide with affinity to the implant surface and an 
AMP motif8,30,31 (Figure 1). Here, we employed titanium (Ti) as a common material used 
for a wide variety of implanted devices.32 The chimeric bifunctional peptide construct 
features high-affinity Ti-binding property on the one end while exposing the AMP motif on 
the other and, hence, forming an effective and highly versatile biomolecular tool to bind to 
the surface while retaining the combating activity against the invading bacteria. In this study, 
two such bifunctional peptides were synthesized, TiBP1-GGG-AMP and TiBP2-GGG-AMP, 
by conjugating each of the two previously identified titanium-binding peptides (TiBP1 and 
TiBP2)23 with an AMP sequence which features well-known cationic properties displaying 
an α-helical structure.33
The designed bifunctional peptides were characterized both in solution and on the Ti surface 
to determine their concomitant solid-binding property and antimicrobial efficacy against 
three bacteria Streptococcus mutans and Staphylococcus epidermidis, as Gram-positive 
ones, and Escherichia coli, as a Gram-negative one. The principles laid out in this work, e.g., 
modularity of the component peptides, could be applied to other AMP sequences with a 
variety of structures and functionalities and expanded to metallic, ceramic, or polymeric 
biomaterial surfaces by using the solid-binding peptides with specific amino acid sequences 
resulting in solid-specific affinities.
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2.1. Peptide Synthesis and Purification
The peptides AMP, TiBP1-GGG-AMP, and TiBP2-GGG-AMP (Table 1) were synthesized 
by a standard solid phase peptide synthesis technique on Wang resin (Novabiochem, San 
Diego, CA) using f-moc chemistry. A CS Bio Co. CS336S automated peptide synthesizer 
(Menlo Park, California, USA) and HBTU activation were used for the synthesis. The 
resulting resin-bound peptides were cleaved and side-chain-deprotected using Reagent K 
(TFA/thioanisole/H2O/phenol/ethanedithiol (87.5:5:5:2.5)) and precipitated by cold ether. 
Crude peptides were purified by RP-HPLC up to >98% purity (Gemini 10u C18 110A 
column). The purified peptides were confirmed by mass spectroscopy (MS) using a MALDI-
TOF mass spectrometer (see Supporting Information Figures S1, S2, and S3). The 4 mM 
stock solutions of each peptide were made in sterile deionized water by dissolving the 
peptides. Subsequent dilutions for experiments were carried out with sterile 1X PBS.
2.2. Titanium Surface Characterization
Surface properties of 0.5 mm thick 99% titanium foil (Alpha Aesar, Cat# 43677) were 
determined by scanning electron microscopy (SEM). The SEM images and EDS spectra 
were recorded at 9 keV accelerating voltage by using a LaB6 filament as the electron source. 
The EDS spectra were collected for 100 s at approximately 1,500 counts per second (cps) 
(see Supporting Information Figure S4).
2.3. Quartz Crystal Microbalance (QCM) Experiments - Determination of Solid-Binding 
Activity of the Peptides
The QCM was used to quantify the values of the binding strength of the titanium-binding 
and bifunctional peptides. Five-megahertz quartz crystals (Q-Sense, Linthicum, MD) were 
coated with 25 nm of titanium via physical vapor deposition, and the coated crystals were 
used in a KSV QCM-D Z500 parallel flow system, which monitors frequency change over 
time. Peptides were diluted in PBS buffer at various concentrations and introduced to the 
crystal surface by a flow cell. The flow was stopped, and the peptides were allowed to bind 
to the surface until reaching equilibrium. Each concentration was flowed several times to 
avoid depletion of the peptide in the flow cell. The binding activity of the peptides was 
observed by the frequency shift, which is directly related to the wet mass of the adsorbed 
peptide. To determine the dissociation constant (KD) of each peptide on the titanium 
substrate, the equilibrium frequency shift caused by peptide binding was measured at several 
concentrations. These values were then fit using the Langmuir adsorption model.23,34–36 
Initially, peptide concentrations of 0.1 to 2 μM were used. These concentrations were then 
adjusted as necessary to be in a similar range as the KD value of each of the peptides. 
Titanium surfaces were, first, cleaned by using a surfactant solution (1% SDS, 1 N NaOH) 
for overnight and then washed with DI water for several times, followed by drying with the 
nitrogen. The crystals were placed under ozone cleaning for 15 min before reuse.
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2.4. Modeling Studies via Molecular Dynamics
We modeled AMP, TiBP1-GGG-AMP, and TiBP2-GGG-AMP by first building linear forms 
using the HyperChem's molecular modeling software (Hyperchem 7.5, USA). The energy 
minimization of these peptides was then carried out under implicit solvent conditions using 
the conformational analysis program. In this procedure, the conformational search module 
finds the minimum-energy structures by varying the chosen dihedral angles toward creating 
new initial structures. In each round of energy minimization, unique low-energy 
conformations are stored, and high-energy and duplicate structures are discarded. Using the 
conformational search module, we found 1,000 different local minima on the potential 
energy surface, and we chose the lowest one as the global minimum or the lowest-energy 
conformation.37,38 Then, the lowest energy conformations are solvated with TIP3P water 
explicitly. Finally the overall system is energy minimized using the Polak-Ribiere conjugate 
gradient method until convergence of the gradient (0.01 kJ/mol) was reached using the 
CHARMM 27 force field.39 The final configurations and the corresponding Ramachandran 
Plots were generated using the VMD (Visual Molecular Dynamics) software40 (see 
Supporting Information Figure S5).
2.5. Circular Dichroism (CD) Spectroscopy Experiments
A solution containing 50 μM peptide, PBS at pH 7.4 was prepared for circular dichroic 
analysis. The spectrum, which is the average of 16 scans from 185–260 nm with a 0.5 nm/s 
scan rate, was collected at 20 °C using an AVIV Stopped Flow 202SF CD 
spectropolarimeter. The averaged spectrum, which was then subtracted with the appropriate 
buffer background, was smoothed using the Savitzky-Golay algorithm. A section of the 
smoothed spectrum (from 190–240 nm) was compared to the five component reference 
spectra [(1) α helix, (2) β sheet, (3) β turn Type-I, (4) β turn Type-II, and (5) random coil] 
compiled by Reed et al., using a constrained least-squares fit. Note that the standard spectra 
do not consider any aromatic nor disulfide dichroic contributions. This is appropriate 
because the analyzed peptides do not contain significant nonstructural features. (TiBP2 
contains only one peptide with an aromatic residue, Y.) The secondary structure estimates 
are reported as the fractional weight ± the standard deviation. All spectral smoothing and 
secondary structure estimation were executed using commercial graphing software (IGOR 
Pro. 6.0). Ellipticity is reported as mean residue ellipticity, θM (deg cm2 dmol−1).
2.6. Bacterial Maintenance and Culturing
Three bacteria species - Escherichia coli ATCC 25922, Streptococcus mutans ATCC 25175, 
and Staphylococcus epidermidis ATCC 29886 - were used in the present study. All of them 
were cultured according to ATCC protocol using the following media: Tripticase Soy Broth 
(TSB) (Fluka, 22092) for E. coli, Brain Heart Infusion (BHI) Broth (Sigma-Aldrich, 53286) 
for S. mutans, and Nutrient Broth (NB) (Difco 0003) for S. epidermidis. For all three 
bacterial species, the bacterial pellet obtained from ATCC was rehydrated in 0.5 mL of the 
above-specified media, and several drops of the suspension were immediately placed and 
streaked on an agar slant of the specified media. The agar-plate was then incubated 
aerobically at 37 °C for 24 h (and in the presence of 5% CO2 in the case of S. mutans). S. 
mutans overnight cultures were made by aseptically transferring a single-colony forming 
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unit into 10 mL of BHI, followed by aerobic incubation at 37 °C in the presence of 5% CO2 
for 16 h under static conditions. Overnight cultures of S. epidermidis and E. coli were made 
by aseptically transferring a single-colony forming unit into 10 mL of NB or TSB 
(respectively), followed by aerobic incubation at 37 °C with constant agitation (200 rpm) for 
16 h.
2.7. In-Solution Antimicrobial Activity of Bifunctional Peptides
The in-solution antimicrobial activities of the peptides were analyzed for S. mutans, S. 
epidermidis, and E. coli spectrophotometrically. For each bacteria species, peptide solutions 
(AMP, TiBP1-GGG-AMP, and TiBP2-GGG-AMP) were added in specified media to reach 
different final concentrations from 10 μM to 200 μM and inoculated with the bacteria to a 
final concentration of 107 cells/mL. Bacterial growth at 37 °C was monitored over the course 
of 24 h by optical density measurements at 600 nm on a Tecan Safire Spectrophotometer No 
I 112 913. For each experiment, a positive control consisting of solely 107 cells/mL of 
bacteria in the specified media and another negative control consisting of only media were 
monitored as well. Additionally, bacterial growth of the three bacteria species in the 
presence of TiBP1 and TiBP2 was also monitored to determine if the titanium-binding 
peptides exhibited any antimicrobial features.
2.8. Titanium Substrate Preparation and Peptide Immobilization
0.5 mm thick, 99% Titanium Foil (Alfa Aesar 43677) was cut into 1 cm × 1 cm squares. The 
titanium substrates were cleaned by sonicating them for 15 min each in a 1:1 
acetone:methanol mixture, then isopropyl alcohol, and finally deionized water. Before 
proceeding any cell adhesion experiment, surface properties and substrate purity were 
examined with SEM and EDX analysis (see Supporting Information, Figure S4).
Following all bacterial-adhesion experiments, substrates were first soaked overnight in a 1:1 
mixture of 20% bleach:70% ethanol before being cleaned by the above regimen. Cleaned 1 
cm2 titanium foil substrates were transferred into a presterilized 24-well plate. The 
substrates were then sterilized under UV light for 15 min on each side. Substrates were 
subsequently incubated aerobically at 37 °C under constant agitation (200 rpm) with 500 μL 
of 1X PBS (positive control), AMP, TiBP1-GGG-AMP, or TiBP2-GGG-AMP solutions for 4 
h. The used peptide concentrations were 200 μM for S. mutans and 50 μM for S. epidermidis 
and E. coli experiments determined by minimal inhibitory peptide concentration for each 
bacteria. Following the 4 h of incubation with peptides, the peptide solutions were removed 
from each well. Twice 1 mL of sterile 1X PBS was then added to each well, pipetted up-and-
down twice, and removed from the well. Using sterile forceps, each titanium substrate was 
moved to a clean well, free of any peptides.
2.9. Bacterial Adhesion on Titanium Surface
To proceed with bacterial adhesion experiments, overnight cultures for each bacterium were 
prepared as described above. Bacteria from the overnight cultures were used to inoculate 
fresh media to a final concentration of 107 cells/mL. Cultures were then incubated in the 
same manner as the overnight cultures were (see Bacterial Maintenance and Culturing), until 
they reached the mid log phase as determined by optical density measurement at 600 nm (S. 
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mutans O.D. ≈ 0.4, S. epidermidis O.D. ≈ 0.25, and E. coli O.D. ≈ 1.0). At the mid log 
phase, the cultures were centrifuged at 4000 rpm for 5 min in a Sorvall RC 5B Plus 
Centrifuge. The supernatant was removed, and the bacterial pellet was resuspended in 500 
μL of specified media. This suspension was then transferred to a 2 mL centrifuge tube and 
centrifuged at 5500 rpm for 3 min in a Fischer Scientific accuSpin Micro Centrifuge. The 
supernatant was carefully removed, and the bacterial pellet was resuspended in sterile 1X 
PBS to a final concentration of 108 cells/mL. Then, 1 mL of the 108 cells/mL cell 
suspension was added to each well containing a peptide-modified titanium substrate and 
incubated for 2 h. For S. mutans experiments, incubation was carried out aerobically at 
37 °C in the presence of 5% CO2 under static conditions; for S. epidermidis and E. coli 
experiments, incubation was carried out aerobically at 37 °C under constant agitation (200 
rpm). After 2 h incubation, first the bacterial suspension was removed, and then the surfaces 
were washed two times with 1 mL of 1X PBS by pipetting. At the end of the experiment, 
adhered cells to titanium substrates were fixed with 500 μL of 2% glutaldehyde (cat # 
18432, Ted Pella, Redding, CA) (in 50 mM Tris Buffer, pH 7.4) for 30 min, followed by 
dehydration in a series of increasing alcohol baths (50% ethanol for 10 min, 70% ethanol for 
10 min, 90% ethanol for 10 min, followed by a 1 mL wash with 100% ethanol).
2.10. Characterization of Bacterial Adhesion on Bifunctional Peptide Modified Titanium 
Substrates
500 μL of 5 μM SYTO9 Green Fluorescent Nucleic acid stain (Invitrogen, S3485) was 
added to each well containing a substrate, protected from light, and incubated for 20 min. 
Substrates were then washed 3 times with 1 mL of 1X PBS by pipetting the PBS up-and-
down two times. Following, the substrates were secured onto a clean microscope slide and 
viewed under a Nikon Eclipse TE2000-U Fluorescent Microscope. Five random images of 
each surface were taken and analyzed for percent surface coverage using Meta Morph 
(Version 6.r6) software. Two independent analyses were conducted and averaged for each 
image. For each substrate, the averaged value for each of the five images that were taken 
from different regions were averaged together and subjected to statistical analysis.
2.11. μ-Contact Printing of TiBP1-GGG-AMP with S. mutans and E. coli
The engineered peptide, TiBP1-GGG-AMP, was stamped onto a clean titanium-substrate in 
a manner previously described.41 The patterned side of the polydimethylsiloxane (PDMS) 
stamp was incubated in 200 μM and 50 μM of TiBP1-GGG-AMP for 5 min, and then the 
peptide solution was removed by pipet from the surface of the stamp to further incubate with 
S. mutans and E. coli, respectively. The stamp was dried with inert gas, followed by a brief 
washing with 1X PBS. The titanium substrate was then applied to the surface of the stamp 
and pressed using force for 10 s and left on the stamp for 1 min. Then the substrate was 
removed from the stamp and washed twice with 1X PBS. The peptide-modified substrates 
were first subjected to the bacterial adhesion and next FM labeling as we described above.
2.12. Statistical Analysis
The surface coverage data of FM was analyzed using SPSS 15.0 software. Statistically 
significant values were defined as p < 0.001 based on Kruskal–Wallis Test, which is the one-
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way analysis of variance. The Mann-Whitney U test was used for multiple comparisons (see 
Supporting Information Tables S1, S2, and S3).
3. RESULTS AND DISCUSSION
Figure 1 demonstrates a chimeric peptide based approach where a resulting peptide having a 
modular structure incorporates functionally different amino acid domains that can be 
synthesized as a single peptide.
3.1. Design of TiBP-AMP Bifunctional Peptides To Functionalize the Titanium Surface
There are multiple factors that may affect the antimicrobial activity of the bound peptides. 
Parameters such as surface concentration of bound AMPs as part of chimeric peptides, 
spacer length to keep bifunctionality of the peptides intact, structural flexibility/rigidity of 
the spacer, molecular conformation, and hydrophobicity of the peptides need to be 
investigated. These properties are interrelated and, which, all together dictate the efficacy of 
AMPs as a domain in a chimeric construct.8,20,42–45
Herein, we demonstrate the use of solid binding peptides as a simple biomolecule for the 
immobilization of AMPs onto the desired biomaterial surface. The solid binding peptides 
offer several advantages, one of which is the biomolecular self-assembly retained in the 
chimeric forms as well as the ease of manipulation via biochemical procedures. Thus, based 
on these promises, we designed bifunctional peptide constructs containing both solid-
binding property to a titanium implant surface and antimicrobial activity against the bacteria. 
Two sets of bifunctional peptides, named, TiBP1-AMP and TiBP2-AMP, were designed and 
synthesized. The conjugation was accomplished using a flexible triple glycine (G) linker, 
which does not interfere with peptide activity in either of the terminals (Table 1).
The main reason for choosing GGG as a flexible spacer is that it is hypothesized to allow 
lateral mobility of the AMP on the solid surface, maintaining its antimicrobial activity. 
Besides the preference of the linker, physicochemical properties of chosen AMPs such as its 
charge and 3D molecular structure also need to be considered for efficiency of the 
antimicrobial activity.8,44 The AMP used herein has an α helical structure and a +6 cationic 
charge. It was conjugated with TiBP1, which is Arg rich and has a +3 cationic charge. In the 
second chimeric system, the AMP was also combined with TiBP2, which is Ser rich with an 
overall neutral charge. The designed bifunctional peptides (TiBP1-GGG-AMP and TiBP2-
GGG-AMP) and AMP alone have different physicochemical properties as listed in Table 1 
in terms of charge, pI, and gravity.
In the design of the bifunctional peptide, the main objective is to retain the functionality of 
each domain, and consequently each domain's capability should display its desired 
functionality and bioactivity. To assess these functionalities quantitatively, two separate 
assays were developed: First, the binding affinity of the peptide constructs to the titanium 
surface was evaluated using QCM. Next, the effect of the overall molecular structure related 
parameters on the antimicrobial activity was analyzed by a combination of techniques 
including CD, molecular modeling, and quantitative imaging studies.
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3.2. Adsorption Behavior of Bifunctional Peptides on the Titanium Surface
Depending on the immobilization strategy, the coverage of the adsorbed peptide on the 
surface affects the degree to which the AMP is effective. This clearly depends on the 
accessibility of the reactive groups of the peptide to the bacterial membrane.8,42,43 There is a 
need to determine critical AMP concentration on the surface or surface coverage for 
suffcient antimicrobial protection.8,42 For this purpose, we used quartz crystal microbalance 
spectroscopy (QCM) to obtain quantitative peptide binding analysis. The adsorption 
behavior of both bifunctional peptides was analyzed by following the frequency shift data 
obtained from the QCM measurements. By converting the frequency shift to the wet-mass 
data and applying the Langmuir adsorption model to the adsorption profiles, we obtained KD 
(dissociation constant) and ΔG (the free energy of adsorption) for each peptide. In these 
analyses, the lower the KD value, the more strongly the peptide binds to the solid surface.
Not surprisingly, both of the bifunctional peptides were found to have stronger binding 
affinities to titanium than the AMP, the control peptide, alone (Table 2). TiBP1-GGG-AMP 
exhibits a 2.85-fold lower KD value than AMP, while TiBP2-GGG-AMP exhibits a 1.5-fold 
lower KD value than AMP. Therefore, TiBP1-GGG-AMP has a stronger binding affinity to 
the Ti surface than the construct using TiBP2. The observed molecular adsorption of the 
AMP alone to the Ti surface may be due to its nonspecific binding affinity. We observe a 
notable degree of nonspecific binding of the AMP to the titanium surface. This may be due 
to the electrostatic interaction between highly charged AMP and the negatively charged 
titanium surface. Regarding peptide-titanium surface interactions, polar and positively 
charged amino acids (Lys, Arg, His, Asp, and Glu) have been considered to have interplay at 
the solid interfaces.46–50 Additionally, the role of metal surface charge on peptide binding 
was also investigated specifically on gold surfaces.
The results reveal that excess negative charge on the gold surface plays an important role on 
the peptide binding properties under nonpolarized conditions.51 In addition to the degree of 
surface binding, the other design criteria, such as total charge, charge distribution, and 
structural folding, and molecular architectural characteristics of peptides, may also play a 
critical role on the retained antimicrobial activity of the chimeric peptide when adsorbed on 
the surface.23,34 In the following section, we provide structural properties for the three 
peptides that have been evaluated for their interactions with the surfaces.
3.3. Molecular Conformation of Bifunctional Peptides
Determining the molecular structure of a novel protein or a peptide is critical to relate to its 
function. The bifunctional peptide constructs are comprised of 29 amino acids and, 
therefore, are amenable to performing CD spectroscopy experiments to analyze their 
molecular conformational structures. Figure 2 (a) shows the CD spectra of the three peptides 
(AMP, TiBP1-GGG-AMP, TiBP2-GGG-AMP) under experimental buffer conditions (PBS 
buffer, see the Experimental Section). Among the three peptides, there are differences in 
terms of their secondary structures. Because of the short sequences, all three peptides exhibit 
mostly unfolded or intrinsically disordered structures, in general, but they also have some 
difference in the degree of beta turn content, a common feature of many short peptides. To 
further analyze the structures and predict ternary conformations, we used computational 
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modeling methods as shown in Figure 2 (b-d). The structure of the AMP (Figure 2 (b)) 
appears to have an α-helical structure, in accord with the literature.33 We next predicted the 
bifunctional peptide structures for both TiBP1-GGG-AMP and TiBP2-GGG-AMP as shown 
in Figure 2 (c) and (d). In these figures, we used two different coloring modes: one for the 
backbone to differentiate the AMP (cyan), linker (yellow), and the TiBP1 (red) and the 
TiBP2 (blue) domains and the other for the side chains to differentiate the polar (green), 
nonpolar (gray), acidic (red), and basic (blue) residues.
These results indicate that the AMP domain preserves its 3-D structure, while linked to the 
solid binding terminal via GGG linkers in both chimera. It is predicted that AMP will 
preserve its function within the context of the dual-functionality. In terms of the interdomain 
interactions between the AMP and the TiBPs, TiBP2 has more interactions compared to 
TiBP1 with the AMP (Figure 2 (c,d)). This may lend that AMP has more functionality while 
linked to TiBP1 compared to TiBP2, the extent of which is also explored and characterized 
by experiments as discussed below. These structural differences may be the result of both the 
amino acid content and the amino acid order of each peptide. Both TiBP1 and AMP contain 
a high number of positively charged residues (Arg, Lys) where TiBP2 has more polar (Ser) 
amino acid content. The models of TiBP1-GGG-AMP indicate each peptide domain poses 
apart from each other (Figure 2 (c)). It has more open structural conformation (i.e., the AMP 
and the TiBP1 domains have more independence from each other) that can be the result of 
the repulsion between the positively charged residues such as Arg in TiBP1 and Lys in AMP. 
This structural feature may improve accessibility and functionality of each peptide domain 
that may affect the antimicrobial properties. TiBP2-GGG-AMP as another designed peptide 
as shown in Figure 2 (d) has more compact and structured features. The reason for this 
compact structure may be due to the attraction force between Ser and Arg.
3.4. Antimicrobial Activity of Bifunctional Peptides in Solution
The antimicrobial efficiency of TiBP-AMP bifunctional peptides was evaluated in solution 
against three species of bacteria S. mutans, S. epidermidis, and E. coli. These chosen 
bacterial species are common in oral and orthopedic implant infections. The “minimum 
inhibitory concentration” (MIC) was determined through optical density measurements by 
testing the stability of each peptide for at least 8 h after the bacteria had entered the mid log 
phase.
To attain the MIC of peptides, the peptide concentration was gradually increased from 10 
μM to 200 μM for each bacterium. Various peptide concentrations at different time points 
were used for S. mutans, as shown in Figure 3 (a) (and also in Figure S6 (a-d), Supporting 
Information). The same experimental setup was utilized for the other two bacteria species 
(S. epidermidis and E. coli) where 10–25 μM and 50 μM peptide concentrations were used, 
respectively, as shown in Figures 3 (b) and 3 (c) (and also in Figure S7 (a-b), Figure S8 (a-b) 
Supporting Information).
Based on the gradually increased peptide concentrations, the MIC was found for two 
bifunctional peptides (TiBP1-GGG-AMP and TiBP2-GGG-AMP) to be 200 μM for S. 
mutans (Figure 3 (a)), 50 μM for S. epidermidis (Figure 3 (b)), and 50 μM for E. coli (Figure 
3 (c)). To complete the analysis of all peptide sequences, the antimicrobial activity of only 
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TiBP1 and TiBP2 was also tested in the presence of each of the three species of bacteria as 
the negative control (Figure S9). As shown in Figure S9, neither of the peptides alone 
displayed any antimicrobial activity at any concentration from 50 to 200 μM tested.
In summary, the antimicrobial activity of the AMP in solution is the most pronounced; 
however, the bifunctional peptides also have significant antimicrobial activity although in 
slightly higher concentrations. More specifically, the AMP is effective in solution at low 
concentrations for S. epidermidis (Gram-positive) and E. coli (Gram-negative) (10 μM) 
(Figure S7 and Figure S8) and for S. mutans at 25 μM (Figure S6). Bifunctional peptide 
efficacy, on the other hand, is recognized at higher peptide concentrations, i.e., 200 μM for 
S. mutans and 50 μM for S. epidermidis and E. coli, respectively.
These results of AMP and its bifunctional molecular constructs in solution may be compared 
with the information in the literature regarding the models on the AMP activity based on 
membrane properties of the Gram-positive and the Gram-negative bacteria.8,18,19,45,52 
Although there is no consensus on the exact biological mechanism of AMPs, some basic 
trends are common in many systems. First of all, it is widely assumed that the cationically 
charged peptides are electrostatically attached to the negatively charged microbial cell 
membrane. Then the AMP assuming an amphipathic structure adapts to the specific 
conditions at the membrane-water interface which leads to an increase in the permeability of 
the cell membrane and loss of barrier function, resulting in the leakage of cytoplasmic 
components and eventual cell death.8,20,53
AMP activity is controlled not only by the membrane structure of the bacteria but also 
through a gene regulation mechanism. This has been proposed to regulate selected resistance 
genes, e.g. dlt-operon, mprF, and vraFG genes, when the bacteria come into contact with the 
AMPs8,16,52,54 and, thereby, limit the interaction with the AMP. Gram-negative bacteria 
have faster permeabilization and killing kinetics compared to Gram-positive bacteria 
according to many studies in the literature.44,55,56 This also confirms the conclusion of 
previous studies that the double membrane of the Gram-negative bacterium is a less efficient 
barrier than the single membrane and the thick peptidoglycan layer of the Gram-positive 
species.52,55
3.5. Antimicrobial Efficacy of the Peptide Functionalized Titanium Surfaces
The effectiveness of the antimicrobial activity of a peptide adsorbed on a solid surface may 
change compared to that in solution. In general, the immobilized AMPs may display an 
increase in their MIC value compared to the soluble peptide. In this part of the research, we 
evaluated the antimicrobial efficacy of each peptide on the Ti substrate using their minimum 
inhibitory concentrations that were determined in solution, namely, 200 μM for S. mutans, 
50 μM for S. epidermidis and E. coli (The characteristics of substrate Ti are shown in Figure 
S4, Supporting Information.).
Peptides were immobilized on the Ti substrate by allowing self-adsorption for an incubation 
time of 4 h at 37 °C with agitation. Upon incubation, the substrate surface was washed twice 
to remove any excess amount of nonspecifically adsorbed peptide. Meanwhile, each 
bacterium was grown until their mid log phase and 108 cells/mL were exposed to the peptide 
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modified titanium surface and incubated for a period of 2 h. After this procedure, the cells 
are fixed and labeled with Syto 9 and visualized under fluoresce microscopy (FM) which 
allowed correlation to be formed between bacterial binding and killing efficacy on the AMP-
coated surfaces. The FM results demonstrate clearly that the amounts of adhered bacteria on 
the bare titanium surface among the three species are significantly different from each other 
(Figure 4, first row). In the presence of S. mutans, the difference in adhered bacteria on the 
peptide-functionalized surface vs the bare surface is significant. Specifically, there is an ~45-
fold difference between the TiBP1-GGG-AMP biofunctionalized titanium surface versus the 
positive control (bare titanium). This is compared with the case where there is an ~20× 
difference with the negative control (only AMP) (Figure 4 left column and Figure 5 (a)). The 
surface antimicrobial activity of TiBP2-GGG-AMP was not as high as TiBP1-GGG-AMP 
although it is higher than the negative control. The difference in the ratio of surface coverage 
between the TiBP2-GGG-AMP modified surface and the negative control is ~2-fold, while 
the difference is ~4-fold with the positive control (Figure 5 (a)). In the presence of S. 
epidermidis, a decrease similar to that in S. mutans was observed in bacterial adhesion 
between the positive control (bare titanium) and the negative control (AMP). However, 
antimicrobial behaviors of TiBP1-GGG-AMP and TiBP2-GGG-AMP were very similar in 
the case of S. epidermidis. The efficiency of TiBP2-GGG-AMP is higher against S. 
epidermidis than that in S. mutans (Figure 4 middle column and Figure 5 (b)). In the case of 
E. coli, AMP was highly efficient to prevent bacterial adhesion on the titanium surface. The 
difference in the ratio of surface coverage between AMP and TiBP1-GGG-AMP is very low. 
Although TiBP2-GGG-AMP had a significant decrease on cell adhesion compared to the 
positive control, the difference relies on the surface coverage ratio not being higher than 
AMP (negative control) (Figure 4 right column and Figure 5 (c)).
The surfaces modified with bifunctional peptides were found to significantly reduce 
bacterial adhesion against all three bacteria when compared to adhesion on bare titanium and 
the AMP functionalized Ti surface.
The substrates modified with TiBP2-GGG-AMP were found to have less bacterial adhesion 
on average than those modified with AMP when incubated with S. mutans and S. 
epidermidis; however; interestingly, they had more bacterial adhesion on average than 
substrates modified with AMP when incubated with E. coli. The solid surfaces modified 
with TiBP1-GGG-AMP were found to reduce bacterial adhesion of S. mutans and E. coli 
better than surfaces modified with TiBP2-GGG-AMP.
The antimicrobial activity of the bifunctional peptides was found to be more profound 
toward Gram-positive bacteria, i.e. S. mutans and S. epidermidis. This may be due to α-
helical conformation of the cationic peptides having two unique features: a net positive 
charge and an amphipathic character that can effect not only the antimicrobial activity but 
also the selectivity between Gram-negative and Gram-positive bacteria.43,44,52
The surface functionalization domain in the case of TiBP1 has a positively charged peptide 
and has a tendency to be an α-helical structure as shown in Figure 2 (c) compared to TiBP2 
as may be observed from the respective Ramachandran plots (Figure S5). Our bifunctional 
peptide TiBP1-GGG-AMP resulted in an increase in the charge value (+9) compared to 
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TiBP2-GGG-AMP (+6) and AMP (+6) alone. Their molecular models reveal that TiBP1-
GGG-AMP has a tendency to have an open structure potentially due to the repulsion 
between charged residues TiBP1 and AMP domains. These repulsions may let bacteria reach 
the AMP domain easier or display the AMP domain better to damage bacterial membrane. 
The molecular model shows that it has turns that are similar to an α-helical structure of 
AMP. Although TiBP2-GGG-AMP has the same charge value, i.e. +6, with AMP it has a 
more compact and closed structure compared to AMP.
The compact molecular structure may have a drastic effect on its antimicrobial efficiency. In 
addition to the molecular structure of the peptides, antimicrobial behavior of bifunctional 
peptides may be further examined in terms of their hydropathy index. First of all, the relative 
hydrophobicity of amino acid residues in a given protein is defined by the values of the 
hydrophobicity scales. The domains of amino acids, which are more positive, are located on 
the more hydrophobic location along a protein sequence. These domains, for example, are 
commonly used to predict the transmembrane α-helices along a given protein sequence. 
Therefore, the hydropathy values of a sequence of a given domain can be an indicator of a 
specific hydrophobic region of a protein inside a lipid bilayer. Since the AMPs have such 
hydrophobic characteristics, the question is whether they retain their antimicrobial function 
when conjugated to solid-binding sequences. The fluorescence microscopy results of the 
chimeric peptides clearly demonstrate (given in Figure 4) the behavior of the overall peptide 
constructs displaying antimicrobial activity when bound to the Ti surface (given in Figure 4).
To understand basic correlation in between peptide function and hydrophobic character, the 
hydropathy index of the peptides was determined, as listed as GRAVY in Table 1. Normally, 
the AMP sequence when examined alone has a hydropathy value of 0.5, i.e., a high potential 
for disrupting the cell membranes. On the contrary, the solid-binding peptides have highly 
negative hydropathy numbers, so they do not have the tendency to interact with the 
negatively charged cell membranes. Since both functionalities are presented in the chimeric 
peptides, it can be concluded that the AMP and the solid binding domain at each of the two 
terminals separated by a flexible GGG linker in the middle retain their biofunctionality, i.e., 
the hydrophobic AMP displaying its hydrophobic chemistry while the solid-binding 
sequences preferring to be bound to the Ti surface. The structurally chimeric peptides, 
therefore, maintain their bifunctionality, just as designed, regardless of the fact that the 
overall peptide sequences are still highly hydropathic (−0.89 and −0.45 for TiBP1 and 
TiBP2, respectively). Maintaining its activity, and while the chimera is still bound to the 
solid substrate via the solid binding domain, the AMP domain is probably an attack on the 
bacterial membrane.
Equally significant to the AMP activity of chimera is the fact that they retain bound to the 
solid surface without disrupting the bioactivity of the functional domain at the opposite 
terminal. Among the two chimera, the bifunctional activity is probably more prominent with 
TiBP1 than with TiBP2 as evidenced from the results in Figures 4, 5, and 6 that show the 
effectiveness of the peptide constructs in deflecting and/or killing the surface-bound 
bacteria. It appears that the TiBP1 bound surface is more hydrophilic than TiBP2 as the 
former has a net charge of 3, while the latter is neutral. The difference in behavior of the Ti-
binding peptides probably is also originating from their conformational behavior on Ti when 
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exposed to the solid. Based on the hydrophobicity values, therefore, the TiBP1 construct 
should work more effectively than TiBP2, confirmed by the observations of its antimicrobial 
activity as shown in Figures 4, 5, and 6.
Overall biological functionality of the chimeric peptide is a result of its molecular folding 
characteristics. In the present case, there is an interplay between the solid binding property 
and antimicrobial activity inherently preserved through the molecular folding that is adapted 
upon adsorption to the solid surface. This appears to be more effective in the case of TiBP1 
compared to TiBP2. In both peptides, however, the introduction of the “GGG” linker turned 
out to be crucial to keep these two separate activity domains from interfering with each other 
to retain their specific functions. Ideally, when bound to the surface the construct should 
make contact with the solid substrate at multiple positions for a better grab of the substrate 
while faithfully displaying the AMP domain extending fully into the solution, effectively 
incorporating into the membrane of the bacteria. Interestingly, extensive molecular dynamics 
studies showed that, probably as a result of kinks across the linker position, the AMP 
domain bends into the solution, away from the solid surface.
As demonstrated by the molecular dynamic modeling studies (Figure 2 (c) and (d)), in both 
constructs, the GGG linker, at the carboxy-terminus, is connected to the AMP with a GL 
sequence, and hence a kink appears in both cases to display the AMP domain into the 
solution. Coincidentally, the GL amino acid sequence also appears in TiBP1 at the amine-
terminus of the GGG linker; therefore, there is an additional kink, possibly affecting the 
display of the AMP domain more freely into the solution, a possible explanation of its high 
effectiveness. This can be seen comparatively in the fluorescence images demonstrating 
antimicrobial activity of the two constructs in Figure 4 third vs fourth rows.
3.6. Bacterial Adhesion Control on the Patterned Titanium Surface
Simple single step peptide based functionalization of surfaces might also provide control of 
bacterial adhesion over different regions; this approach could be useful for creating specific 
surface regions to analyze different bacterial species. We next investigated if the bacterial 
adhesion could be controlled under certain patterns using simple chimeric peptide motifs. 
We examined the difference in bacterial adhesion behavior on bare titanium as well as the 
titanium surface functionalized with TiBP1-GGG-AMP. The peptide was stamped on the 
surface using a soft lithography technique, i.e. PDMS stamp, and antibacterial efficacy of the 
TiBP1-GGG-AMP was tested against S. mutans and E. coli on the patterned areas (Figure 
6). The observed bacterial pattern in Figure 6 demonstrates the ease of applying the peptide 
on the surface for any type of pattern to decorate surfaces for a variety of applications, 
analysis of bacterial growth, susceptibility, or protecting certain high risk regions.
Building upon experimental findings, bifunctional peptides have demonstrated improved 
antimicrobial activity on the surfaces in the presence of three different sets of bacteria using 
a simple single step surface functionalization procedure. TiBP1-GGG-AMP demonstrated 
the best antimicrobial activity between the two bifunctional peptides on the titanium implant 
materials being more efficient against S. mutans.
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Here we demonstrate the applicability of chimeric peptides as antimicrobial implant 
coatings; however, their effects on osteoblast-like cells need to be further evaluated. M. 
Kazemzadeh-Narbat et al. previously showed that loading one of the antimicrobial peptides 
(HHC-36) onto octacalcium phosphate (OCP) coatings in self-organized TiO2 nanotube 
arrays did not negatively affect MG-63 osteoblast-like cells. They also reported 
incorporation of antimicrobial peptides (HHC-36) into OCP coatings could even moderately 
enhance bone growth in vivo.31,57 In another study, Zhang et al. demonstrated the 
differentiation of circulating monocytes treated with an antimicrobial peptide called LL-37 
resulted in novel bone forming cells. Monocytes are often recruited to sites of injury and 
may differentiate into various cell types including osteoclasts, and the peptide interaction 
may contribute to bone repair.58 Similarly Kraus et al. reported a positive role of Human β-
Defensins, which is a class of antimicrobial peptides, in proliferation, differentiation, and 
mineralization of MG-63 osteoblast-like cells.59 In different studies, human MSCs were 
shown to produce LL-37 having a role in the prevention of bacterial infection.60,61 It is quiet 
interesting to note that so far studies have been showing the preferred action of antimicrobial 
peptides to be on the prokaryotic membranes rather than eukaryotic membranes. AMPs and 
functionalizing surfaces using bioenabled approaches with AMPs may provide an interesting 
avenue to explore combating bacterial infection in a bimimetic way.
4. CONCLUSIONS
Herein, we offer a simple way toward tailoring biomaterial surfaces capable of preventing 
bacterial infection by using engineered chimeric peptide based surface biofunctionalization. 
We designed two chimeric peptides comprised of titanium binding and antimicrobial peptide 
(AMP) motifs; these bifunctional peptides rely on the titanium-binding property that allows 
the molecular construct to preferentially bind to the biomaterial while freely exposing the 
AMP motif to combat invading bacteria. The efficacy of our bifunctional peptides, TiBP1-
GGG-AMP and TiBP2-GGG-AMP, was evaluated both in-solution and on the solid surface 
of titanium substrate against Streptococcus mutans, Staphylococcus epidermidis, and 
Escherichia coli. Surfaces modified with both of the chimeric peptides were found to 
significantly reduce bacterial adhesion against all three bacteria compared to the bare 
titanium. The results of the presented work indicate that surface modification with 
engineered biomolecules consisting of antimicrobial and titanium-binding peptide domains 
is a promising approach to prevent bacterial infection on implant surfaces. Based on the 
chimeric approach that incorporates modular units various peptides can be designed against 
a broad range of bacteria by utilizing sequence, structure, and charge relations of AMPs and 
solid-binding peptides. The controlled binding to and release of biomolecules on implant 
surfaces are critical in the development of smart implant materials. More detailed studies 
may be necessary to test the underlying mechanism of antimicrobial activity in such 
bioconjugated peptides using a variety of modular sequences and to determine the stability 
of adsorbed peptides on the implant surface in a variety of biological conditions, including 
change in pH, buffers, and body fluids.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Chimeric peptide design to incorporate solid binding and antimicrobial peptide for 
bifunctionality.
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(a) CD spectra of peptides (50 μM peptide in PBS) and (b-d) molecular dynamics models of 
the peptides. The colors of the amino acids shown in the CPK representation indicate the 
following residues: white, nonpolar; green, polar; red, acidic; and blue, basic.
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Minimum inhibitory concentration of peptides (AMP and bifunctional counterparts) against 
Streptococcus mutans (a), Staphylococcus epidermidis (b), and Escherichia coli (c).
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Bacterial adhesion on AMP, TiBP1-Spacer-AMP, and TiBP2-Spacer-AMP peptide modified 
titanium surfaces against Streptococcus mutans (left column), Staphylococcus epidermidis 
(middle column), and Escherichia coli (right column).
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Surface coverage analysis of titanium surfaces functionalized by the peptides, i.e. AMP, 
TiBP1-Spacer-AMP, and TiBP2-Spacer-AMP against Streptococcus mutans (a), 
Staphylococcus epidermidis (b), and Escherichia coli (c), *p < 0.01 compared to titanium 
bare, **p < 0.01 compared to AMP, #p < 0.01 comparison in between TiBP1-Spacer-AMP 
and TiBP2-Spacer-AMP.
Yazici et al. Page 24














Stamping chimeric peptide on a titanium substrate provides control of the bacterial adhesion 
on desired patterns. a) Schematics of PDMS patterning of the engineered chimeric peptide 
on the Ti substrate; b) Adhesion of S. mutans and E. coli (108 cell/mL) on the patterned 
peptide array; c) FM images of Syto9 labeled S. mutans and E. coli on the patterned peptide 
array.
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Table 1
Molecular Characteristics of the Engineered Peptides Used in This Work
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Table 2
Binding Affinity of the Peptides on Titanium Determined by Using QCM Measurementa
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